The total amount of T cells used in treating ovarian mice was 8 × 106 cells/mouse, which is significantly lower than the traditional dosage required for treating ovarian cancer in mice with HER-2-CAR-T (2 × 107 cells/mouse) (30). This evidence concerns the gene ERBB2 and ovarian cancer.